Generated by GPT-5-mini| mBio | |
|---|---|
| Title | mBio |
| Discipline | Microbiology |
| Abbreviation | mBio |
| Publisher | American Society for Microbiology |
| Country | United States |
| Frequency | Continuous, online |
| History | 2010–present |
| License | Creative Commons |
| Impact factor | (varies annually) |
mBio
mBio is a peer-reviewed, open-access scientific journal published by the American Society for Microbiology that covers research in the biological sciences with emphasis on microbiology, infectious disease, virology, immunology, and microbial ecology. The journal publishes original research articles, reviews, commentaries, and special issues intended for a global audience of researchers, clinicians, and public-health professionals. mBio is designed to accelerate dissemination of findings relevant to pathogens, host responses, microbial physiology, and translational interventions.
mBio publishes interdisciplinary work linking experimental studies, clinical reports, and field investigations from contributors affiliated with institutions such as Harvard University, Stanford University, Massachusetts Institute of Technology, University of Oxford, University of Cambridge, Johns Hopkins University, University of California, Berkeley, University of California, San Francisco, Yale University, Columbia University, Imperial College London, Karolinska Institutet, Max Planck Society, Cold Spring Harbor Laboratory, Scripps Research, University of Tokyo, Peking University, University of Toronto, McGill University, ETH Zurich, University of Melbourne, University of Sydney, University of São Paulo, University of Cape Town, Seoul National University, National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, Bill & Melinda Gates Foundation, Wellcome Trust, Howard Hughes Medical Institute, European Molecular Biology Laboratory, Broad Institute, Los Alamos National Laboratory, Rockefeller University, Ragon Institute, Fred Hutchinson Cancer Center, Mount Sinai Health System, Karolinska Institutet.
mBio was launched in 2010 by the American Society for Microbiology during a period of rapid expansion in online and open-access publishing that included milestones such as the rise of PLOS, the reform efforts exemplified by Plan S, and debates following high-profile publications from groups at Cold Spring Harbor Laboratory and Salk Institute. Early editorial leadership drew on figures from institutions including Harvard Medical School, Yale School of Medicine, Oxford University Clinical Research Unit, and Institut Pasteur. The journal’s creation paralleled developments at publishers like Nature Publishing Group, Science (journal), Cell Press, BMJ Group, Elsevier, and Springer Nature and coincided with policy shifts at funding agencies such as the National Institutes of Health and foundations like the Wellcome Trust that emphasized open dissemination.
The journal’s scope spans basic and applied studies on bacteria, archaea, viruses, fungi, protozoa, microbiomes, antimicrobial resistance, vaccine development, diagnostic methods, and host-pathogen interactions. Its editorial board has included researchers from centers such as Stanford School of Medicine, Harvard School of Public Health, Johns Hopkins Bloomberg School of Public Health, University of Washington School of Medicine, University of Pittsburgh School of Medicine, University of California, San Diego, Duke University School of Medicine, University of Michigan Medical School, Washington University in St. Louis School of Medicine, University of Texas Southwestern Medical Center, University of Edinburgh, University College London, Pasteur Institute, Institut Pasteur de Dakar, National University of Singapore, Monash University, Trinity College Dublin, University of Copenhagen, Karolinska Institutet, Rijksinstituut voor Volksgezondheid en Milieu, Institut Pasteur de Paris. Peer review processes align with standards promoted by organizations such as Committee on Publication Ethics and reference initiatives associated with ORCID, CrossRef, and DOAJ.
mBio is indexed in major services and databases, aiding discoverability alongside journals indexed by PubMed, MEDLINE, Web of Science, Scopus, Google Scholar, EMBASE, BIOSIS Previews, Academic Search Premier, CAB Abstracts, SciFinder, Index Medicus, ProQuest, EBSCOhost, Dimensions, CrossRef, and platform services used by libraries at institutions such as Harvard Library, British Library, Library of Congress, Bibliothèque nationale de France, Deutsche Nationalbibliothek, National Diet Library (Japan), National Library of Medicine, National Library of Australia.
mBio has been cited in policy discussions and public-health responses involving outbreaks and pandemics addressed by agencies such as the Centers for Disease Control and Prevention, World Health Organization, European Centre for Disease Prevention and Control, Africa Centres for Disease Control and Prevention, and research consortia including GISAID, Coalition for Epidemic Preparedness Innovations, October 2014 Ebola response, and COVID-19 pandemic initiatives. Articles have informed clinical practice guidelines issued by professional societies like the Infectious Diseases Society of America, American Thoracic Society, European Society of Clinical Microbiology and Infectious Diseases, British Society for Antimicrobial Chemotherapy, and have been cited in reviews published by publishers such as Oxford University Press, Cambridge University Press, and Springer. mBio content has been discussed in media outlets including Nature (journal), Science (journal), The New York Times, The Guardian, The Washington Post, BBC News, Reuters, Associated Press, NPR.
Notable papers and issues have addressed topics such as antimicrobial resistance, viral evolution, zoonotic spillover, and microbiome therapeutics with contributions from investigators at Centers for Disease Control and Prevention, National Institutes of Health, Oxford University Clinical Research Unit, Broad Institute, Sanger Institute, Wellcome Sanger Institute, Los Alamos National Laboratory, Harvard T.H. Chan School of Public Health, Imperial College London, University of Hong Kong, Wuhan Institute of Virology, Institut Pasteur, National Institute for Communicable Diseases (South Africa), Johns Hopkins University, Purdue University, Cornell University, University of Wisconsin–Madison, Michigan State University, Texas A&M University, Iowa State University, University of Florida, University of Minnesota, University of Illinois Urbana–Champaign, Arizona State University, University of Arizona, Rutgers University, Northwestern University, Vanderbilt University. Special issues have been curated in partnership with organizations such as Wellcome Trust, Bill & Melinda Gates Foundation, Howard Hughes Medical Institute, and collaborative networks including Human Microbiome Project, Earth Microbiome Project, and outbreak-response consortia.
Category:Open access journals Category:Microbiology journals Category:American Society for Microbiology journals